NASDAQ$ALHC
Alignment Healthcare Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Alignment Healthcare's Q3 results demonstrated the company's success in Medicare Advantage through high-quality care and effective cost management.
Alignment Healthcare reported excellent third-quarter results, highlighting their success in delivering high-quality care while effectively managing costs within the Medicare Advantage program. The company's focus on the Triple Aim has driven positive outcomes in stars, growth, and profitability.
- Alignment Healthcare reported strong third-quarter results.
- The company's success is attributed to delivering high-quality care and managing costs effectively.
- Alignment Healthcare is confident in its platform to provide the best care at the lowest cost.
- The company aims to drive long-term value for members and shareholders.
Headline financials
Revenue & EPS history
Alignment Healthcare · Revenue · Quarterly
$692M
Revenue by segment
Alignment Healthcare · $265M total across 2 segments · Q1 2021
- Earned premiums$265M+18.0%100.0%
- Other revenue$82K—0.0%
Forward guidance
The company provided an outlook for the fourth quarter and fiscal year 2024.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
+1.8%
Avg return
Earnings day
+1.8%
Avg return
5 days after
+2.6%
Avg return
30 days after
57%
12 / 21 earnings
Positive
+27.0%
Q1 2024
Best reaction
-16.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.8% | -15.7% | -29.5% | |
| Q4 2025 | -5.8% | -7.5% | -18.6% | |
| Q3 2025 | -1.9% | -0.4% | +12.2% | |
| Q1 2025 | -7.7% | -7.5% | -8.3% | |
| Q4 2024 | +16.5% | +17.4% | +35.9% | |
| Q3 2024 | +1.6% | +12.2% | +11.2% | |
| Q2 2024 | +2.3% | +4.9% | +3.1% | |
| Q1 2024 | +27.0% | +31.6% | +51.0% | |
| Q4 2023 | -8.9% | -9.2% | -20.1% | |
| Q3 2023 | -9.6% | -7.2% | +10.5% | |
| Q2 2023 | +7.5% | +10.5% | -4.2% | |
| Q1 2023 | +3.5% | +11.3% | -5.1% | |
| Q4 2022 | -16.4% | -20.9% | -35.2% | |
| Q3 2022 | -3.1% | -3.3% | -2.7% | |
| Q2 2022 | +10.4% | +4.3% | -8.7% | |
| Q1 2022 | -7.0% | -18.8% | +6.8% | |
| Q4 2021 | +10.7% | +8.0% | +39.7% | |
| Q3 2021 | +10.6% | +6.1% | -26.7% | |
| Q2 2021 | -8.5% | -4.8% | -11.2% | |
| Q1 2021 | +6.8% | +13.3% | +27.6% | |
| Q4 2020 | +6.8% | +13.3% | +27.6% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro